Equity

12 Months Ended

Dec. 31, 2021

Equity [Abstract]

Equity

Equity

At-The-Market Offering Program. The Company maintains an At-The-Market offering program ("ATM program") under which the Company can issue common shares. The following table summarizes common share issuances under the ATM program:

	Year ended December 31, 2021
	Shares Sold	Net Proceeds
2021 ATM Issuances	1,052,800	$13,532
	Year ended December 31, 2020
	Shares Sold	Net Proceeds
2020 ATM Issuances	5,950,882	$60,977

During 2021, the Company settled 4,990,717 common shares previously sold on a forward basis on the maturity date of the contract and received $53,567 of net proceeds. There were no forward settlements during 2020.

As of December 31, 2021, an aggregate of 3,649,023 common shares were sold in forward sales contracts that had not been settled and had an aggregate settlement price of $38,544, which is subject to adjustment in accordance with the forward sales contracts. The Company expects to settle the forward sales contracts by the maturity dates in February 2022.

In 2021, the Company amended the terms of its ATM offering program, under which the Company may, from time to time, sell up to $350,000 of common shares over the term of the program. As of December 31, 2021, commons shares with an aggregate value of $294,985 remain available for issuance under the ATM program.

Underwritten Equity Offerings. During 2021, the Company entered into forward sales contracts for the sale of 16,000,000 common shares at a public offering price of $12.11 per common share in an underwritten equity offering that have not yet settled. Subject to the Company's rights to elect cash or net share settlement, the Company expects to settle the forward sales contracts by the maturity date in May 2022. As of December 31, 2021, the forward sales contracts had an aggregate settlement price $187,528, which is subject to adjustment in accordance with the forward sales contracts.

During 2020, the Company issued 17,250,000 common shares at $9.60 per common share in an underwritten offering and generated net proceeds of approximately $164,000. The net proceeds were used for general corporate purposes, including acquisitions, and pending the application of the proceeds were used to pay down all the then outstanding balance under the Company's revolving credit facility.

Stock Based Compensation. In addition, during the years ended December 31, 2021, 2020 and 2019, the Company issued 949,573, 756,380 and 896,807 of its common shares, respectively, to certain employees and trustees. Typically, trustee share grants vest immediately. Employee share grants generally vest ratably, on anniversaries of the grant date, however, in certain situations vesting is cliff-based after a specific number of years and/or subject to meeting certain performance criteria.

Share Repurchase Program. In July 2015, the Company's Board of Trustees authorized the repurchase of up to 10,000,000 common shares and increased this authorization by 10,000,000 in 2018. This share repurchase program has no expiration date. During 2020 and 2019, the Company repurchased and retired, 1,329,940 and 441,581 common shares, respectively, at an average price of, $8.28 and $8.13, respectively, per common share under the share repurchase program. During 2021, there were no share repurchases. As of December 31, 2021, 8,976,315 common shares remain available for repurchase under this authorization. The Company records a liability for repurchases that have not yet been settled as of the period end.

Series C Preferred Stock. The Company had 1,935,400 shares of Series C Cumulative Convertible Preferred Stock (“Series C Preferred”) outstanding at December 31, 2021. The shares have a dividend of $3.25 per share per annum, have a liquidation preference of $96,770, and the Company, if certain common share prices are achieved, can force conversion into common shares of the Company. As of December 31, 2021, each share was convertible into 2.4339 common shares. This conversion ratio may increase over time if the Company's common share dividend exceeds certain quarterly thresholds.

If certain fundamental changes occur, holders may require the Company, in certain circumstances, to repurchase all or part of their shares of Series C Preferred. In addition, upon the occurrence of certain fundamental changes, the Company will, under certain circumstances, increase the conversion rate by a number of additional common shares or, in lieu thereof, may in certain circumstances elect to adjust the conversion rate upon the shares of Series C Preferred becoming convertible into shares of the public acquiring or surviving company.

The Company may, at the Company's option, cause shares of Series C Preferred to be automatically converted into that number of common shares that are issuable at the then prevailing conversion rate. The Company may exercise its conversion right only if, at certain times, the closing price of the Company's common shares equals or exceeds 125% of the then prevailing conversion price of the Series C Preferred.

Holders of shares of Series C Preferred generally have no voting rights, but will have limited voting rights if the Company fails to pay dividends for six or more quarters and under certain other circumstances. Upon conversion, the Company may choose to deliver the conversion value to investors in cash, common shares, or a combination of cash and common shares.

A summary of the changes in accumulated other comprehensive income (loss) related to the Company's cash flow hedges is as follows:

	Twelve months ended December 31,
	2021		2020
Balance at beginning of period	$	(17,963)	$	(1,928)
Other comprehensive income (loss) before reclassifications	6,755		(19,422)
Amounts of loss reclassified from accumulated other comprehensive loss to interest expense	4,950		3,387
Balance at end of period	$	(6,258)	$	(17,963)

Noncontrolling Interests. In conjunction with several of the Company's acquisitions in prior years, sellers were issued limited partner interests in LCIF (“OP units”) OP units as a form of consideration. All OP units, other than OP units owned by the Company, are redeemable for common shares at certain times, at the option of the holders, and are generally not otherwise mandatorily redeemable by the Company. The OP units are classified as a component of permanent equity as the Company has determined that the OP units are not redeemable securities as defined by GAAP. Each OP unit is currently redeemable for approximately 1.13 common shares, subject to future adjustments.

During 2021, LCIF redeemed and cancelled 1,598,906 OP units in connection with the disposition of the three properties.

During 2021, 2020 and 2019, 185,270, 327,453 and 391,993 common shares, respectively, were issued by the Company, in connection with OP unit redemptions, for an aggregate value of $958, $1,614 and $1,655, respectively.

As of December 31, 2021, there were approximately 775,000 OP units outstanding other than OP units owned by the Company. All OP units receive distributions in accordance with the LCIF partnership agreement. To the extent that the Company's dividend per common share is less than the stated distribution per OP unit per the LCIF partnership agreement, the distributions per OP unit are reduced by the percentage reduction in the Company's dividend per common share. No OP units have a liquidation preference.

The following discloses the effects of changes in the Company's ownership interests in its noncontrolling interests:

	Net Income Attributable to Shareholders and Transfers from Noncontrolling Interests
	2021		2020		2019
Net income attributable to LXP Industrial Trust shareholders	$	382,648	$	183,302	$	279,910
Transfers (to) from noncontrolling interests:
Increase (decrease) in additional paid-in-capital for reallocation of noncontrolling interests	435		—		(973)
Increase in additional paid-in-capital for redemption of noncontrolling OP units	958		1,614		1,655
Change from net income attributable to shareholders and transfers from noncontrolling interests	$	384,041	$	184,916	$	280,592